P&G stock: 3 things to watch before Monday’s open
11 January 2026
1 min read

P&G stock: 3 things to watch before Monday’s open

New York, Jan 11, 2026, 11:34 EST — Market closed

  • Procter & Gamble shares edged up 0.24% on Friday, trailing the S&P 500’s 0.65% gain. 1
  • U.S. CPI figures for December will be released Jan. 13 at 8:30 a.m. ET, with November retail sales set to come out the next day, Jan. 14. 2
  • P&G will report fiscal second-quarter results on Jan. 22 at 8:30 a.m. ET. 3

Procter & Gamble (PG) shares ended Friday roughly 0.2% higher, closing at $141.87. The modest gain kept the consumer-staples giant essentially flat heading into the weekend.

This is crucial now since the next market move will probably hinge on interest rates. Even a slight change in inflation expectations can nudge Treasury yields and shake up “defensive” stocks — the reliable earners investors turn to when growth feels uncertain.

P&G occupies a central spot in that dynamic. The company sells everyday essentials, and its earnings often influence investor views on pricing power within the staples sector.

Staples saw a boost Friday. The Consumer Staples Select Sector SPDR Fund (XLP) climbed roughly 1%, with Colgate-Palmolive up 0.7% and Clorox jumping 1.9%.

Over the weekend, CNBC’s Jim Cramer weighed in on P&G, labeling it a “complicated, unloved stock.” He added that the new CEO “has the opportunity to shake things up.” 4

P&G appointed insider Shailesh Jejurikar as chief executive starting Jan. 1, the company announced in a filing. Jon Moeller will step into the role of executive chairman. 5

Investors will focus on clear signs around volume and pricing when the company reports later this month. Volume reflects unit demand, showing if customers are actually buying more items rather than just paying higher prices. Price/mix sums up gains from increased prices and customers opting for premium versions.

The Bureau of Labor Statistics has the Consumer Price Index set for Tuesday, followed by the Producer Price Index on Wednesday, according to its January schedule. 6

Retail sales for November are set for release on Jan. 14, according to the Census Bureau’s schedule. This will offer a snapshot of consumer spending as 2025 wrapped up. 7

Earnings season kicks into gear this week as major banks and key bellwethers report, delivering results that could shift risk appetite—even among slow-growth staples. 8

The setup works both ways. Hotter inflation readings could push yields higher, weighing on dividend-heavy consumer stocks. Signs that shoppers are trading down would also cast doubt on the pricing story.

P&G announced it will webcast a discussion of its fiscal second-quarter earnings on Jan. 22 at 8:30 a.m. ET. Traders are eyeing this as the next key catalyst for the stock. 9

Stock Market Today

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

7 February 2026
Kenvue shares closed Friday at $18.13, up 0.33%, with about 63.5 million shares traded. The Kimberly-Clark offer values Kenvue at roughly $18.76 per share, leaving a deal spread of about 3%. Both companies’ shareholders approved the merger, which is expected to close in the second half of 2026 pending regulatory approvals. Kenvue’s dividend record date is Feb. 11, with earnings due Feb. 17.
IREN stock heads into Monday after 5% rebound as Microsoft AI financing stays in focus

IREN stock heads into Monday after 5% rebound as Microsoft AI financing stays in focus

7 February 2026
IREN shares closed up 5.1% at $41.83 Friday after reporting a $155.4 million quarterly loss and $184.7 million in revenue. The company announced $3.6 billion in GPU financing for its Microsoft contract, with $2.8 billion in cash as of Jan. 31. Bitcoin mining revenue fell, while AI cloud services rose. Traders await bitcoin’s weekend move and Monday’s market reaction.
Roche stock: $570 million MediLink cancer-drug deal puts Swiss shares back in focus
Previous Story

Roche stock: $570 million MediLink cancer-drug deal puts Swiss shares back in focus

Chevron stock (CVX) heads into Monday with Venezuela output boost in spotlight
Next Story

Chevron stock (CVX) heads into Monday with Venezuela output boost in spotlight

Go toTop